Case Study
Fast-Track Clinical Transition from Lipid-based Solution to Lipid-based Suspension in Softgels
A clinical-stage biotech focused on neurology faced challenges with a lipophilic, oxidation-sensitive molecule limited by solubility, stability, and scalability.
View Now
Case Study
From IV to Oral: Leveraging Softgel to Extend Vinorelbine’s Lifecycle & Improve Patient Convenience
Vinorelbine, a chemotherapy agent traditionally given by IV infusion, was reformulated into the first approved oral softgel capsule through a collaboration between Pierre Fabre and Catalent.
View Now
Webinars
Fast, Flexible, Bioavailable: Lipid-Based Softgels for BCS I–IV
Bringing complex oral drugs to the clinic requires overcoming significant solubility, permeability, and bioavailability challenges.
View Now
Executive Summary
Oral Lipid-Based Formulations: Unlocking Value in Early-Stage Pharmaceutical Development
Summary: Pharmaceutical innovators face growing pressure to overcome solubility, permeability, and bioavailability challenges, especially for complex, poorly soluble molecules.
View Now
Webinars
Why This Proven Dosage Form is Underutilized and How to Leverage It
Softgels are a versatile and scalable platform for pharmaceutical development with the ability to improve bioavailability, enhance patient compliance, and accommodate diverse formulations.
View Now
Case Study
Optimizing SG Shell Formulation
Learn how our proprietary expertise and proven techniques provide stable, integrated softgel solutions that achieve development goals.
View Now
Webinars
Oral Lipid-Based Formulations: Unlocking Value in Early-Stage Pharmaceutical Development
Join our expert-led panel to explore innovative formulation strategies, the diverse mechanisms of action, preclinical and clinical considerations, as well as encapsulation techniques, and more.
View Now
Executive Summary
From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Formulations and Softgels
Summary: Softgels are ideal for LBF delivery and are compatible with various formulations. Innovations like delayed release and plant-based capsules enhance drug delivery. LBFs with a Quality-by-Design approach offer an efficient route to market for complex drugs.
View Now
Article
Harnessing Softgels for Patient-Centric Drug Delivery
Learn how softgel capsules have advanced drug delivery by encapsulating a variety of active pharmaceutical ingredients (APIs).
View Now
Webinars
From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Formulations and Softgels
Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.
View Now